Publicacions en col·laboració amb investigadors/es de Hospital San Pedro (8)

2023

  1. Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer

    EMBO Reports, Vol. 24, Núm. 8

2022

  1. Analysis of the albumin-bilirubin score as an indicator of improved liver function among hepatitis C virus patients with sustained viral response after direct-acting antiviral therapy

    JGH Open, Vol. 6, Núm. 7, pp. 496-502

  2. Impact of the Acceptance of the Recommendations Made by a Meropenem Stewardship Program in a University Hospital: A Pilot Study

    Antibiotics, Vol. 11, Núm. 3

2020

  1. International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

    Liver International, Vol. 40, Núm. 6, pp. 1467-1476

2017

  1. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study

    European Journal of Haematology, Vol. 98, Núm. 1, pp. 38-43

2015

  1. Immune monitoring of immunosuppression withdrawal of liver transplant recipients

    Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116

1994

  1. Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr

    Journal of Acquired Immune Deficiency Syndromes, Vol. 7, Núm. 7, pp. 635-640

1991

  1. Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide

    Journal of Hepatology, Vol. 12, Núm. 2, pp. 170-175